TARGETED THERAPY MARKET ANALYSIS

Targeted Therapy Market, by Type (Small Molecule Medicines and Monoclonal Antibodies), by Application (Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Dec 2021
Code : CMI4835
Pages :225
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Targeted Therapy Market: Restraint

Cost is a major factor influencing the selection of targeted therapy products. The drugs prescribed in targeted therapy treatment are often prohibitively expensive. Thus, higher cost of therapy is likely to hamper the growth of market. For instance, monthly averages of targeted therapy is US$ 5,000 to US$ 10,000 and annual totals over US$ 100,000.

Global Targeted Therapy Market – Impact of Coronavirus (COVID-19) Pandemic

COVID-19 causes several challenges to cancer practice, especially to ensure continuity of treatment during this period. It has significantly affected healthcare systems and economies within a short timeframe. Various diagnostic & research centres had to slow their activity due to public health measures. Thus, the emerging cancer research was affected due to the COVID-19.

However, targeted therapy is being evaluated in COVID-19 treatment. Thus, by encouraging clinicians to pursue targeted therapy agents during the pandemic is likely expected to create opportunity during the forecast period.